-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: healthcare
Gates Foundation Issues Biotech Call to Action
Today, Trevor Mundel from the Bill & Melinda Gates Foundation discussed the untapped potential of biotech companies to help develop new and better drugs, vaccines, diagnostics, and delivery systems for global health solutions at the 2014 BIO International Convention. This is important because 90 percent of the global infectious disease burden is borne by those who live in developing countries, yet the foundation believes that little attention is paid to health solutions to address these Read More >
Integrate and Collaborate to Drive Advancements in Oncology Treatments
Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, from improvements in screening to the development of more personalized, treatments. In a 2014 BIO International Convention Super Session on Tuesday moderated by BioCentury Editor Susan Schaeffer, panelists discussed the pressing need for companies to increase collaboration with each other and with industry stakeholders, including patient advocacy groups and academic medical centers, to speed the development and delivery of new Read More >
Transforming Healthcare through Digital Innovation
Imagine being connected to expert health coaches on a daily basis instead of only at your annual doctor’s visit. What would it be like to be told on a real-time, continuous basis how many minutes of exercise at a specific heart rate was required, foods you needed to eat, and behaviors you needed to avoid in order to be feel better and be healthier? What if this information meant you could get off your hypertensive medications Read More >
New NPC Report on Comparative Effectiveness Research
Advances in medical research create the potential for better health outcomes, improved treatment and even prevention of once-fatal diseases and, with these improvements, a more cost-effective healthcare system. How we use research is the key to achieving a healthier society. That’s what makes the new publication by the National Pharmaceutical Council (NPC), “2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making” so valuable. This is the fourth year that NPC has conducted a Read More >
Alzheimer’s Association offers Research Grant Program
The Alzheimer’s Association offers the Part the Cloud Translational Research Grant Program, which aims to fill the gap in Alzheimer’s disease drug development. The program supports early phase studies of potential Alzheimer’s therapeutics or validation of biological markers of disease progression and moves us closer to potential therapies to stop or slow the progression of Alzheimer’s. More information is available at alz.org/grants. There is no greater health care need than slowing or preventing Alzheimer’s disease. Read More >
